These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Effect of instillation of aldose reductase inhibitor FR74366 on diabetic cataract. Ao S; Kikuchi C; Ono T; Notsu Y Invest Ophthalmol Vis Sci; 1991 Nov; 32(12):3078-83. PubMed ID: 1834606 [TBL] [Abstract][Full Text] [Related]
4. A selective aldose reductase inhibitor of a new structural class prevents or reverses early retinal abnormalities in experimental diabetic retinopathy. Sun W; Oates PJ; Coutcher JB; Gerhardinger C; Lorenzi M Diabetes; 2006 Oct; 55(10):2757-62. PubMed ID: 17003340 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of aldose reductase by flavonoids: possible attenuation of diabetic complications. Varma SD Prog Clin Biol Res; 1986; 213():343-58. PubMed ID: 3086893 [No Abstract] [Full Text] [Related]
7. A new approach against sugar cataract through aldose reductase inhibitors. Banditelli S; Boldrini E; Vilardo PG; Cecconi I; Cappiello M; Dal Monte M; Marini I; Del Corso A; Mura U Exp Eye Res; 1999 Nov; 69(5):533-8. PubMed ID: 10548473 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of lens aldose reductase by flavonoids--their possible role in the prevention of diabetic cataracts. Varma SD; Kinoshita JH Biochem Pharmacol; 1976 Nov; 25(22):2505-13. PubMed ID: 825129 [No Abstract] [Full Text] [Related]
10. Altering the course of cataracts in diabetic rats. Fukushi S; Merola LO; Kinoshita JH Invest Ophthalmol Vis Sci; 1980 Mar; 19(3):313-5. PubMed ID: 6766909 [TBL] [Abstract][Full Text] [Related]
11. Effect of sorbitol dehydrogenase inhibition on sugar cataract formation in galactose-fed and diabetic rats. Kador PF; Inoue J; Secchi EF; Lizak MJ; Rodriguez L; Mori K; Greentree W; Blessing K; Lackner PA; Sato S Exp Eye Res; 1998 Aug; 67(2):203-8. PubMed ID: 9733586 [TBL] [Abstract][Full Text] [Related]
12. Effects of a new aldose reductase inhibitor on diabetic complications in rats. Gervasi GB; Bartoli C; Catalani R; Farina C; Carpita G; Caccia G; Ammannati P Arzneimittelforschung; 1991 Nov; 41(11):1160-3. PubMed ID: 1810261 [TBL] [Abstract][Full Text] [Related]
13. Taxifolin Shows Anticataractogenesis and Attenuates Diabetic Retinopathy in STZ-Diabetic Rats Liu F; Ma Y; Xu Y Endocr Metab Immune Disord Drug Targets; 2020; 20(4):599-608. PubMed ID: 31656158 [TBL] [Abstract][Full Text] [Related]
14. Aldose reductase and the etiology of diabetic cataracts. Varma SD Curr Top Eye Res; 1980; 3():91-155. PubMed ID: 6807610 [No Abstract] [Full Text] [Related]
15. Effect of aldose reductase inhibitors on naphthalene cataract formation in the rat. Tao RV; Takahashi Y; Kador PF Invest Ophthalmol Vis Sci; 1991 Apr; 32(5):1630-7. PubMed ID: 1901836 [TBL] [Abstract][Full Text] [Related]
16. Inhibitory effects of Ganoderma applanatum on rat lens aldose reductase and sorbitol accumulation in streptozotocin-induced diabetic rat tissues. Jung SH; Lee YS; Shim SH; Lee S; Shin KH; Kim JS; Kim YS; Kang SS Phytother Res; 2005 Jun; 19(6):477-80. PubMed ID: 16114079 [TBL] [Abstract][Full Text] [Related]
17. Sorbinil prevention of diabetic-like retinopathy in the galactose-fed rat model. Robison WG; Laver NM; Jacot JL; Glover JP Invest Ophthalmol Vis Sci; 1995 Nov; 36(12):2368-80. PubMed ID: 7591626 [TBL] [Abstract][Full Text] [Related]
18. Effects of aldose reductase inhibitor (M79175) on ERG oscillatory potential abnormalities in streptozotocin fructose-induced diabetes in rats. Funada M; Okamoto I; Fujinaga Y; Yamana T Jpn J Ophthalmol; 1987; 31(2):305-14. PubMed ID: 3118085 [TBL] [Abstract][Full Text] [Related]
19. Diabetic-like retinopathy in rats prevented with an aldose reductase inhibitor. Robison WG; Nagata M; Laver N; Hohman TC; Kinoshita JH Invest Ophthalmol Vis Sci; 1989 Nov; 30(11):2285-92. PubMed ID: 2509395 [TBL] [Abstract][Full Text] [Related]